These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12977879)

  • 21. A trial of antigen marianum as an adjunct of D.D.S. in the treatment of lepromatous leprosy.
    BECKETT DW
    Lepr Rev; 1958 Oct; 29(4):209-14. PubMed ID: 13589102
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of the derivatives of diamino-diphenyl sulphone in leprosy, a guide.
    RAY AT
    Indian Med J; 1950 Oct; 44(10):228-9; passim. PubMed ID: 14794212
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of the derivatives of diamino-diphenyl sulphone in leprosy. A guide.
    ROY AT
    Antiseptic; 1951 Jan; 48(1):9-12. PubMed ID: 14820036
    [No Abstract]   [Full Text] [Related]  

  • 24. [The initial period of artificial pneumothorax: the effect of para-aminosalicylic acid and dihydrostreptomycin on the frequency of pleural effusion and on pulmonary function].
    BIRATH G
    Dis Chest; 1953 Sep; 24(3):245-58. PubMed ID: 13095239
    [No Abstract]   [Full Text] [Related]  

  • 25. Leprosy under treatment with diamino-diphenyl sulphone (two cases).
    WADDINGTON E
    Proc R Soc Med; 1951 Aug; 44(8):681-2. PubMed ID: 14864570
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of diaminodiphenylsulfone and thiosemicarbazone in the treatment of lepromatous leprosy; clinical and bacteriological evaluation in sixty hospitalized patients.
    SAGHER F; BRAND N
    Int J Lepr; 1953; 21(2):161-7. PubMed ID: 13096167
    [No Abstract]   [Full Text] [Related]  

  • 27. Derivatives of diaminodiphenylsulfone and heterocyclic sulfones in experimental tuberculosis.
    FREEDLANDER BL; FRENCH FA
    Am Rev Tuberc; 1947 Oct; 56(4):360-4. PubMed ID: 20270483
    [No Abstract]   [Full Text] [Related]  

  • 28. Response of tuberculosis to intensive combined four drug therapy.
    KASK E
    J La State Med Soc; 1957 Apr; 109(4):121-7. PubMed ID: 13416774
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case of leprosy treated by combined use of equal weights of two new di-substituted sulfones: diphenyl sulfone 4, 4'-bis (azo-para-isopropyl-metacresol) and its silver salts].
    TZANCK A; BASSET A; SALOMON L
    Bull Mem Soc Med Hop Paris; 1952 Jun 20-27; 68(22-23):749-52. PubMed ID: 12978850
    [No Abstract]   [Full Text] [Related]  

  • 30. Radioactive tracer studies on uptake of di-amino-diphenyl-sulphone by leprosy patients.
    CHATTERJEE KR; PODDAR RK
    Proc Soc Exp Biol Med; 1957 Jan; 94(1):122-5. PubMed ID: 13400890
    [No Abstract]   [Full Text] [Related]  

  • 31. [Catamnesis of tuberculous meningitis from 1946 to 1954 with special reference to the follow-up examination of survivors].
    GILARDI A
    Ann Paediatr; 1957 Jun; 188(6):349-66. PubMed ID: 13435589
    [No Abstract]   [Full Text] [Related]  

  • 32. [Considerations on para-aminosalicylic acid and on dihydrostreptomycin].
    ROSSITTO G
    G Sci Mediche; 1950 Jul; 5(7):136-41. PubMed ID: 14793778
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical evaluation studies in lepromatous leprosy; third series: nicotinamide, and BCG vaccination as supplements to diaminodiphenyl sulfone (DDS).
    DOULL JA; RODRIGUEZ JN; DAVISON AR; TOLENTINO JG; FERNANDEZ JV
    Int J Lepr; 1958; 26(3):219-35. PubMed ID: 13640759
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative in vitro response of tubercle bacillus (H37RV) to dihydrostreptomycin, para-aminosalicylic acid, and dihydrostreptomycin-para-aminosalicylate.
    VENNESLAND K; ALTONA J; BLOCH RG
    Proc Soc Exp Biol Med; 1950 Nov; 75(2):436-8. PubMed ID: 14808284
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical evaluation studies in lepromatous leprosy. 4. 4, Butoxy-4'dimethylaminodiphenyl thiourea (DPT), amodiaquin, and 4-4'diaminodiphenyl sulfone (DDS) 2.5 mgm, and 4 mgm. per kg. of body weight.
    DOULL JA; RODRIGUEZ JN; TOLENTINO JG; FERNANDEZ JV; GUINTO RS; RIVERA JN; MABALAY MC
    Int J Lepr; 1961; 29():291-317. PubMed ID: 13887566
    [No Abstract]   [Full Text] [Related]  

  • 36. [Practical superiority of diamino-diphenyl-sulfone (1358 F) over complex disubstituted sulfones in the treatment of leprosy].
    FLOCH G; DESTOMBES P
    Med Trop (Mars); 1950; 10(1):61-72. PubMed ID: 15429396
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sulfone therapy in lepromatous children at Colônia Santa Isabel, Brazil].
    ORSINI O; TAVARES I
    Arq Min Leprol; 1951 Jan; 11(1):16-33. PubMed ID: 14869252
    [No Abstract]   [Full Text] [Related]  

  • 38. A five-year assessment of patients in a controlled trial of streptomycin, para-aminosalicylic acid, and streptomycin plus para-aminosalicylic acid, in pulmonary tuberculosis.
    FOX W; SUTHERLAND I
    Q J Med; 1956 Apr; 25(98):221-43. PubMed ID: 13323251
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of leprosy].
    AMALFITANO G; GAMBINI G; MERUCCI P
    Acta Med Ital Mal Infett Parassit; 1951 Dec; 6(12):329-31. PubMed ID: 12975972
    [No Abstract]   [Full Text] [Related]  

  • 40. Relapses after sulfone therapy in leprosy of the lepromatous type.
    RODRIGUEZ JN
    Int J Lepr; 1959; 26(4):305-12. PubMed ID: 13672660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.